CLARET ASSET MANAGEMENT Corp increased its holdings in shares of HEXO Corp. (NASDAQ:HEXO) by 23.3% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 47,640 shares of the company’s stock after purchasing an additional 9,000 shares during the quarter. CLARET ASSET MANAGEMENT Corp’s holdings in HEXO were worth $188,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also bought and sold shares of the company. River & Mercantile Asset Management LLP purchased a new position in HEXO in the 2nd quarter worth approximately $351,000. Toronto Dominion Bank boosted its holdings in HEXO by 26.5% in the 2nd quarter. Toronto Dominion Bank now owns 130,084 shares of the company’s stock worth $694,000 after acquiring an additional 27,231 shares during the period. Ladenburg Thalmann Financial Services Inc. boosted its holdings in HEXO by 208.9% in the 2nd quarter. Ladenburg Thalmann Financial Services Inc. now owns 19,867 shares of the company’s stock worth $106,000 after acquiring an additional 13,435 shares during the period. UBS Asset Management Americas Inc. boosted its holdings in HEXO by 36.5% in the 2nd quarter. UBS Asset Management Americas Inc. now owns 123,900 shares of the company’s stock worth $663,000 after acquiring an additional 33,100 shares during the period. Finally, Cubist Systematic Strategies LLC boosted its holdings in HEXO by 8.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 172,162 shares of the company’s stock worth $920,000 after acquiring an additional 14,062 shares during the period.
HEXO has been the subject of a number of analyst reports. MKM Partners initiated coverage on HEXO in a report on Friday, September 20th. They issued a “buy” rating and a $12.00 price target for the company. Zacks Investment Research cut HEXO from a “buy” rating to a “hold” rating in a report on Thursday. Roth Capital cut HEXO from a “buy” rating to a “neutral” rating in a report on Friday. Bank of America cut HEXO from a “buy” rating to an “underperform” rating and decreased their price target for the stock from $9.00 to $4.00 in a report on Monday, October 7th. Finally, TheStreet cut HEXO from a “c-” rating to a “d+” rating in a report on Monday, July 22nd. One analyst has rated the stock with a sell rating, five have assigned a hold rating and five have issued a buy rating to the company. HEXO presently has an average rating of “Hold” and a consensus price target of $7.67.
HEXO Company Profile
HEXO Corp., through its subsidiary, HEXO Operations Inc, produces, markets, and sells cannabis in Canada. The company offers dried cannabis under the Time of Day and H2 lines; Elixir, a cannabis oil sublingual mist product line; and Decarb, an activated fine-milled cannabis powder product. It provides its products under the HEXO and Hydropothecary brand names.
Featured Article: Do back-end load funds outperform no-load funds?
Want to see what other hedge funds are holding HEXO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HEXO Corp. (NASDAQ:HEXO).
Receive News & Ratings for HEXO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HEXO and related companies with MarketBeat.com's FREE daily email newsletter.